About Portage Biotech
Portage Biotech is a company based in Tortola (British Virgin Islands) founded in 2013.. Portage Biotech has completed 2 acquisitions, including Tarsus Rx and Tarus Therapeutics. Portage Biotech offers products and services including iNKT Platform, Adenosine Platform, and Other Programs.
- Headquarter Tortola, British Virgin Islands
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Portage Biotech Inc.
-
Annual Revenue
$00as on Mar 31, 2024
-
Net Profit
$-6.77 M91.02as on Mar 31, 2024
-
EBITDA
$-7.38 M59.43as on Mar 31, 2024
-
Latest Funding Round
$36.08 M (USD), Post-IPO
Sep 02, 2025
-
Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Tarsus Rx
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Portage Biotech
Portage Biotech is a publicly listed company on the NASDAQ with ticker symbol ATON in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Portage Biotech
Portage Biotech offers a comprehensive portfolio of products and services, including iNKT Platform, Adenosine Platform, and Other Programs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops therapies targeting cancer resistance pathways through immune activation
Focuses on novel assets for cancer treatment via adenosine modulation
Advances preclinical assets for diverse cancer resistance mechanisms
Funding Insights of Portage Biotech
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $36.1M
-
First Round
First Round
(15 Jun 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2025 | Amount | Post-IPO - Portage Biotech | Valuation |
investors |
|
| Jan, 2025 | Amount | Post-IPO - Portage Biotech | Valuation |
investors |
|
| Aug, 2022 | Amount | Post-IPO - Portage Biotech | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Portage Biotech
Portage Biotech has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Tarsus Rx and Tarus Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cancer therapeutics targeting the adenosine pathway are developed.
|
2019 | ||||
|
Proprietary drugs for blepharitis treatment are developed by Tarsus.
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Portage Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Portage Biotech Comparisons
Competitors of Portage Biotech
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Portage Biotech
Frequently Asked Questions about Portage Biotech
When was Portage Biotech founded?
Portage Biotech was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Where is Portage Biotech located?
Portage Biotech is headquartered in Tortola, British Virgin Islands.
Who is the current CEO of Portage Biotech?
Alexander Pickett is the current CEO of Portage Biotech.
What does Portage Biotech do?
Portage Biotech was founded in 2013 in Tortola and operates in the biotechnology sector, focusing on pharmaceutical product development through clinical proof of concept. Emphasis is placed on orphan drugs and targeted therapies for cancer, infectious diseases, neurology, and psychiatry. Products are licensed or sold to larger firms post-proof. Subsidiaries include Portage Pharmaceuticals Ltd for CPP-based treatments and Biohaven for glutamatergic agents addressing neuropsychiatric disorders.
What products or services does Portage Biotech offer?
Portage Biotech offers iNKT Platform, Adenosine Platform, and Other Programs.
Is Portage Biotech publicly traded?
Yes, Portage Biotech is publicly traded on NASDAQ under the ticker symbol ATON.
How many acquisitions has Portage Biotech made?
Portage Biotech has made 2 acquisitions, including Tarsus Rx, and Tarus Therapeutics.
What is Portage Biotech's ticker symbol?
The ticker symbol of Portage Biotech is ATON on NASDAQ.